New Cardiac Devices Get Investors' Hearts Pumping

A hot new technology. A widespread, deadly disease. A whole lot of money changing hands. That was the story last Wednesday when St. Jude Medical (STJ) agreed to pay $3.4 billion in cash for Thoratec (THOR), developer of an implant called the left ventricular assist device (LVAD), which helps heart-failure patients keep their blood moving. And lately it's been the story in the whole field of cardiology devices. Breakthroughs in technology suggest

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

STJ [+]    THOR [+]    LVAD [+]   

More #news: